INBX
Inhibrx Biosciences, Inc.
97.00$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | – | |
| 255.5% | 18.2% | – | 475.0% | – | 689.0% | – | 50.9% | – | – | – | – | – | |
| -155.5% | 81.8% | – | 100.0% | – | -589.0% | – | 49.1% | – | – | – | – | – | |
| 31,980.7% | 5,008.5% | – | 67,632.0% | – | 33,367.0% | – | 1,712.8% | – | – | – | – | – | |
| 6,629.4% | 479.3% | – | 93,366.0% | – | 16,661.0% | – | 494.0% | – | – | – | – | – | |
| 38,354.6% | 5,485.0% | – | 160,998.0% | – | 49,339.0% | – | 2,155.9% | – | – | – | – | – | |
| -38,510.1% | -5,403.2% | – | -160,898.0% | – | -49,928.0% | – | -2,106.8% | – | – | – | – | – | |
| 6,847.9% | 503.2% | – | 5,361.0% | – | 0.0% | – | 241.6% | – | – | – | – | – | |
| -43,518.5% | -5,728.8% | – | 1,858,013.0% | – | -47,865.0% | – | -2,204.0% | – | – | – | – | – | |
| 1.7% | -0.2% | – | 2.0% | – | – | – | 0.2% | – | – | – | – | – | |
| -43,520.2% | -5,728.5% | – | 1,858,011.0% | – | -47,865.0% | – | -2,204.2% | – | – | – | – | – | |
| -36,415.1% | -5,385.0% | – | 1,863,374.0% | – | -47,176.0% | – | -1,911.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.